Recruitment of host's progenitor cells to sites of human amniotic fluid stem cells implantation

Biomaterials

Volumn 32, Issue 18, 2011, Pages 4218-4227

  Mirebella, Teodelinda ^a,b   Poggi, Alessandro ^b   Scaranari, Monica ^b   Mogni, Massimo ^c   Lituania, Mario ^c   Baldo, Chiara ^c   Cancedda, Ranieri ^a,b   Gentili, Chiara ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

Author keywords

Angiogenesis; In vitro test; In vivo test; Inflammation; Mesenchymal stem cells; Tissue engineering

Indexed keywords

ANGIOGENESIS; IN VITRO TEST; IN-VIVO TESTS; INFLAMMATION; MESENCHYMAL STEM CELL;

CELL CULTURE; EMPLOYMENT; FLUIDS; GENE EXPRESSION; HYDROXYAPATITE; PATHOLOGY; SCAFFOLDS (BIOLOGY); TISSUE;

STEM CELLS;

FAT; HYDROXYAPATITE; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR SOX2;

AMNION FLUID; ANIMAL CELL; ARTICLE; BONE; CELL CULTURE; CELL DENSITY; FIBROBLAST; FIBROMA; GENE EXPRESSION; HUMAN; IMMUNOREGULATION; KARYOTYPE; MESENCHYMAL STEM CELL; MESODERM; MOUSE; MULTIPOTENT STEM CELL; MUSCLE; NONHUMAN; PRIORITY JOURNAL; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION;

AMNIOTIC FLUID; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; KARYOTYPING; LEUKOCYTES, MONONUCLEAR; MICE; MICE, NUDE; MULTIPOTENT STEM CELLS; REGENERATIVE MEDICINE; STEM CELLS; T-LYMPHOCYTES;

MUS MUSCULUS;

EID: 79955087102     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.028     Document Type: Article

References (46)

1. Caplan A.I. Mesenchymal stem cells. J Orthop Res 1991, 9(5):641-650.
2. Roubelakis M.G., Pappa K.I., Bitsika V., Zagoura D., Vlahou A., Papadaki H.A., et al. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 2007, 16(6):931-952.
3. Walther G., Gekas J., Bertrand O.F. Amniotic stem cells for cellular cardiomyoplasty: promises and premises. Catheter Cardiovasc Interv 2009, 73(7):917-924.
4. De Coppi P., Bartsch G., Siddiqui M.M., Xu T., Santos C.C., Perin L., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007, 25(1):100-106.
5. Pappa K.I., Anagnou N.P. Novel sources of fetal stem cells: where do they fit on the developmental continuum?. Regen Med 2009, 4(3):423-433.
6. Marcus A.J., Coyne T.M., Black I.B., Woodbury D. Fate of amnion-derived stem cells transplanted to the fetal rat brain: migration, survival and differentiation. J Cell Mol Med 2008, 12(4):1256-1264.
7. Perin L., Sedrakyan S., Da Sacco S., De Filippo R. Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol 2008, 86:85-99.
8. Buoni S., Zannolli R., Macucci F., Pucci L., Mogni M., Pierluigi M., et al. Familial robertsonian 13;14 translocation with mental retardation and epilepsy. J Child Neurol 2006, 21(6):531-533.
9. Prusa A.R., Marton E., Rosner M., Bernaschek G., Hengstschlager M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?. Hum Reprod 2003, 18(7):1489-1493.
10. Atala A. Recent developments in tissue engineering and regenerative medicine. Curr Opin Pediatr 2006, 18(2):167-171.
11. Tasso R., Augello A., Boccardo S., Salvi S., Carida M., Postiglione F., et al. Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A 2009, 15(8):2203-2212.
12. Tasso R., Fais F., Reverberi D., Tortelli F., Cancedda R. The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Biomaterials 2010, 31(8):2121-2129.
13. Kolambkar Y.M., Peister A., Soker S., Atala A., Guldberg R.E. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 2007, 38(5):405-413.
14. Corselli M., Parodi A., Mogni M., Sessarego N., Kunkl A., Dagna-Bricarelli F., et al. Clinical scale ex vivo expansion of cord blood-derived outgrowth endothelial progenitor cells is associated with high incidence of karyotype aberrations. Exp Hematol 2008, 36(3):340-349.
15. Moretta A., Poggi A., Pende D., Tripodi G., Orengo A.M., Pella N., et al. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J Exp Med 1991, 174(6):1393-1398.
16. Musso A., Zocchi M.R., Poggi A. Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T cell proliferation and B cell survival. Haematologica 2010, [Epub ahead of print].
17. Prevosto C., Zancolli M., Canevali P., Zocchi M.R., Poggi A. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 2007, 92(7):881-888.
18. Martin I., Muraglia A., Campanile G., Cancedda R., Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997, 138(10):4456-4462.
19. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131(2):324-336.
20. Rittie L., Fisher G.J. Isolation and culture of skin fibroblasts. Methods Mol Med 2005, 117:83-98.
21. Ellison D., Rigg J., McConnell S.J., Alexander A.D., Yager R.H. Use of antibiotics in the preparation of Canine kidney tissue culture Vaccines to Eliminate Leptospiral Infection Hazards. Appl Microbiol 1965, 13:595-599.
22. Igarashi S. A simple enzymatic method for isolation of hepatocytes. Experientia 1977, 33(10):1401-1402.
23. Kruisbeek A.M. Isolation of mouse mononuclear cells. Curr Protoc Immunol 2001, [Chapter 3]:Unit 3.1.
24. Bianchi G., Banfi A., Mastrogiacomo M., Notaro R., Luzzatto L., Cancedda R., et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003, 287(1):98-105.
25. Rubio D., Garcia-Castro J., Martin M.C., de la Fuente R., Cigudosa J.C., Lloyd A.C., et al. Spontaneous human adult stem cell transformation. Cancer Res 2005, 65(8):3035-3039.
26. Miura M., Miura Y., Padilla-Nash H.M., Molinolo A.A., Fu B., Patel V., et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006, 24(4):1095-1103.
27. Sessarego N., Parodi A., Podesta M., Benvenuto F., Mogni M., Raviolo V., et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 2008, 93(3):339-346.
28. Katebi M., Soleimani M., Cronstein B.N. Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. J Leukoc Biol 2009, 85(3):438-444.
29. Eltzschig H.K., Thompson L.F., Karhausen J., Cotta R.J., Ibla J.C., Robson S.C., et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 2004, 104(13):3986-3992.
30. Mariotti E., Mirabelli P., Abate G., Schiattarella M., Martinelli P., Fortunato G., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow and placenta: CD10, CD49d, and CD56 make a difference. Stem Cells Dev 2008, 17(6):1039-1041.
31. Brooke G., Tong H., Levesque J.P., Atkinson K. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev 2008, 17(5):929-940.
32. Nomura T., Ashihara E., Tateishi K., Ueyama T., Takahas-Hi T., Yamagishi M., et al. Therapeutic potential of stem/progenitor cells in human skeletal muscle for cardiovascular regeneration. Curr Stem Cell Res Ther 2007, 2(4):293-300.
33. Moretta A., Olive D., Poggi A., Pantaleo G., Mawas C., Moretta L. Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen-dependent and antigen-independent pathways of human T cell activation. Eur J Immunol 1986, 16(11):1427-1432.
34. Zanders E.D., Lamb J.R., Feldmann M., Green N., Beverley P.C. Tolerance of T-cell clones is associated with membrane antigen changes. Nature 1983, 303(5918):625-627.
35. Dugger K., Lowder T.W., Tucker T.A., Schwiebert L.M. Epithelial cells as immune effector cells: the role of CD40. Semin Immunol 2009, 21(5):289-292.
36. Rutishauser R.L., Kaech S.M. Generating diversity: transcriptional regulation of effector and memory CD8 T-cell differentiation. Immunol Rev 2010, 235(1):219-233.
37. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110(10):3499-3506.
38. Matsumoto T., Mifune Y., Kawamoto A., Kuroda R., Shoji T., Iwasaki H., et al. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol 2008, 215(1):234-242.
39. Revoltella R.P., Papini S., Rosellini A., Michelini M., Franceschini V., Ciorba A., et al. Cochlear repair by transplantation of human cord blood CD133+ cells to nod-scid mice made deaf with kanamycin and noise. Cell Transplant 2008, 17(6):665-678.
40. T.A.R Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J 2006, 20:1045-1054.
41. Elices M.J.O.L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990, 60(4):577-584.
42. Perin L., Sedrakyan S., Giuliani S., Da Sacco S., Carraro G., Shiri L., et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One 2010, 5(2):e9357.
43. De Coppi P., Callegari A., Chiavegato A., Gasparotto L., Piccoli M., Taiani J., et al. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 2007, 177(1):369-376.
44. Yoon B.S., Moon J.H., Jun E.K., Kim J., Maeng I., Kim J.S., et al. Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Stem Cells Dev 2010, 19(6):887-902.
45. Muraglia A., Martin I., Cancedda R., Quarto R. A nude mouse model for human bone formation in unloaded conditions. Bone 1998, 22(5 Suppl):131S-134S.
46. Tortelli F., Tasso R., Loiacono F., Cancedda R. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials 2010, 31(2):242-249.